- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2013
- Public Summary Document (PSD) November 2013 PBAC Meeting - PDF
Adalimumab – November 2013
Adalimumab, 40mg/0.8mL injection, 0.8 mL cartridges and 0.8mL syringes, Humira®
Last updated
8 November 2023